Mitochondrial Approaches for Neuroprotection

Cites (314)

Items 201–312 of 312

1. MitoQ--a mitochondria-targeted antioxidant.
   Joseph S. Tauskela · 2007 · PubMed
2. PGC-1α, a New Therapeutic Target in Huntington's Disease?
   McGill, Jetta K., Beal, M. Flint · 2006 · Cell
3. Resistance Training With Creatine Monohydrate Improves Upper-Body Strength in Patients With Parkinson Disease: A Randomized Trial
   Chris J. Hass, Mitchell A. Collins, Jorge L. Juncos · 2007 · Neurorehabilitation and neural repair
4. Improved Reperfusion and Neuroprotection by Creatine in a Mouse Model of Stroke
   Prass, Konstantin, Royl, Georg, Lindauer, Ute, Freyer, Dorette, Megow, Dirk, Dirnagl, Ulrich, Stöckler-Ipsiroglu, Gerda, Wallimann, Theo, Priller, Josef · 2007 · Journal of Cerebral Blood Flow & Metabolism
5. Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice
   Smith, Karen M., Matson, Samantha, Matson, Wayne R., Cormier, Kerry, Del Signore, Steven J., Hagerty, Sean W., Stack, Edward C., Ryu, Hoon, Ferrante, Robert J. · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
6. Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation
   Ole A. Andreassen, Bruce G. Jenkins, Alpaslan Dedeoglu, Kimberly L. Ferrante, Mikhail B. Bogdanov, Rima F Kaddurah-Daouk, M. Flint Beal · 2001 · Journal of Neurochemistry
7. The nutritional biochemistry of creatine
   Greenhaff, Paul L. · 1997 · The Journal of Nutritional Biochemistry
8. A Controlled Study of 2 Doses of Idebenone in the Treatment of Alzheimer’s Disease
   Weyer, G., Babej-Dölle, R.M., Hadler, D., Hofmann, S., Herrmann, W.M. · 2008 · Neuropsychobiology
9. Superoxide production by mitochondria in the presence of nitric oxide forms peroxynitrite
   Packer, Michael A., Porteous, Carolyn M., Murphy, Michael P. · 1996 · IUBMB Life
10. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson’s disease
    Simon, David K, Lin, Michael T, Zheng, Leiya, Liu, Guang-Jun, Ahn, Colette H, Kim, Lauren M, Mauck, William M, Twu, Florence, Beal, M.Flint, Johns, Donald R · 2004 · Neurobiology of Aging
11. Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment
    Wim Derave, Ludo Van Den Bosch, Griet Lemmens, Bert O. Eijnde, Wim Robberecht, Peter Hespel · 2003 · Neurobiology of Disease
12. Lipoic acid improves survival in transgenic mouse models of Huntington's disease
    Andreassen, Ole A., Ferrante, Robert J., Dedeoglu, Alpaslan, Beal, M. Flint · 2001 · Neuroreport
13. Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice
    Stack, Edward C., Smith, Karen M., Ryu, Hoon, Cormier, Kerry, Chen, Minghua, Hagerty, Sean W., Del Signore, Steven J., Cudkowicz, Merit E., Friedlander, Robert M., Ferrante, Robert J. · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
14. Cortical Motor-Sensory Hypometabolism in Amyotrophic Lateral Sclerosis
    Jun Hatazawa, Rufus Brooks, Marinos C. Dalakas, Luigi Mansi, Giovanni Di Chiro · 1988 · Journal of Computer Assisted Tomography
15. Creatine improves health and survival of mice
    Andreas Bender, Johannes Beckers, Ilka Schneider, Sabine M. Hölter, Tobias B. Haack, Tanja Ruthsatz, Daniela M. Vogt Weisenhorn, Lore Becker, Just Genius, Dan Rujescu et al. · 2007 · Neurobiology of Aging
16. Determination of creatine kinase kinetic parameters in rat brain by NMR magnetization transfer. Correlation with brain function
    A. Sauter, Markus Rudin · 1993 · Journal of Biological Chemistry
17. Effect of oral creatine supplementation on muscle [PCr] and short-term maximum power output
    L. Maureen Odland, J. DUNCAN MacDOUGALL, Mark Andrew Tarnopolsky, A. Elorriaga, Anne I. Borgmann · 1997 · Medicine & Science in Sports & Exercise
18. Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease
    Alice S. Chen‐Plotkin, Ghazaleh Sadri‐Vakili, George J. Yohrling, Melissa W. Braveman, Caroline Benn, Kelly E. Glajch, Derek P. DiRocco, Laurie A Farrell, Dimitri Krainc, Sílvia Ginés et al. · 2006 · Neurobiology of Disease
19. Guanidinoacetate methyltransferase deficiency: New clinical features
    Ganesan, Vijeya, Johnson, Andrew, Connelly, Alan, Eckhardt, Susan, Surtees, Robert A.H. · 1997 · Pediatric Neurology
20. The Putative Rat Choline Transporter CHOT1 Transports Creatine and Is Highly Expressed in Neural and Muscle-Rich Tissues
    Patrick D. Schloss, Wolfgang Mayser, Heinrich Betz · 1994 · Biochemical and Biophysical Research Communications
21. Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity
    Schulz, Jörg B., Ross Henshaw, D., Matthews, Russell T., Flint Beal, M. · 1995 · Experimental Neurology
22. In vitro complex formation between the octamer of mitochondrial creatine kinase and porin.
    Dieter G. Brdiczka, Philipp Kaldis, Theo Wallimann · 1994 · Journal of Biological Chemistry
23. Cerebral Synaptic Transmission During Anoxia Is Protected by Creatine
    Tim S. Whittingham, Peter Lipton · 1981 · Journal of Neurochemistry
24. Coenzyme Q10 Provides Neuroprotection in Iron-Induced Apoptosis in Dopaminergic Neurons
    Patcharee Kooncumchoo, Sushil Kumar SHARMA, James E. Porter, Piyarat Govitrapong, Manuchir Ebadi · 2006 · Journal of Molecular Neuroscience
25. Does the mitochondrial genome play a role in the etiology of Alzheimer’s disease?
    Joanna L. Elson, Corinna Herrnstadt, Gwen Preston, Leon J. Thal, Christopher M. Morris, J.A. Edwardson, M. Flint Beal, Douglass M. Turnbull, Neil Howell · 2006 · Human Genetics
26. ‘Hot spots’ of creatine kinase localization in brain: cerebellum, hippocampus and choroid plexus
    Kaldis, Philipp, Hemmer, Wolfram, Zanolla, Else, Holtzman, David, Wallimann, Theo · 2009 · Developmental Neuroscience
27. Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease
    Kuwert, T., Boecker, H., Titz, H., Herzog, H., Wang, B. -C., Nayak, U., Feinendegen, L. E., Lange, H. W., Aulich, A. · 1993 · Journal of Neurology
28. Frataxin gene of Friedreich's ataxia is targeted to mitochondria
    Josef Priller, Clemens R. Scherzer, Peter W. Faber, Marcy E. MacDonald, Anne B. Yong · 1997 · Annals of Neurology
29. Ubiquinone Protects Cultured Neurons against Spontaneous and Excitotoxin-Induced Degeneration
    Favit, Antonella, Nicoletti, Ferdinando, Scapagnini, Umberto, Canonico, Pier Luigi · 1992 · Journal of Cerebral Blood Flow & Metabolism
30. Neuroprotection of Creatine Supplementation in Neonatal Rats with Transient Cerebral Hypoxia-Ischemia
    Adcock, Kathryn H., Nedelcu, Johann, Loenneker, Thomas, Martin, Ernst, Wallimann, Theo, Wagner, Bendicht P. · 2002 · Developmental Neuroscience
31. A controlled trial of idebenone in Huntington's disease
    Ranen, Neal G., Peyser, Carol E., Coyle, Joseph T., Bylsma, Frederick W., Sherr, Meeia, Day, Leslie, Folstein, Marshal F., Brandt, Jason, Ross, Christopher A., Folstein, Susan E. · 1996 · Movement Disorders
32. Effects of an Inhibitor of Poly(ADP-Ribose) Polymerase, Desmethylselegiline, Trientine, and Lipoic Acid in Transgenic ALS Mice
    Andreassen, Ole A., Dedeoglu, Alpaslan, Friedlich, Avi, Ferrante, Kimberly L., Hughes, Duncan, Szabo, Cesar, Beal, M.Flint · 2001 · Experimental Neurology
33. Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation
    Ferdinando Squitieri, Milena Cannella, Gianluca Sgarbi, Vittorio Maglione, Alessandra Falleni, Paola Lenzi, Alessandra Baracca, Giuliana Cislaghi, Carsten Saft C, Giuseppe Ragona et al. · 2005 · Mechanisms of Ageing and Development
34. Phosphocreatine-dependent Glutamate Uptake by Synaptic Vesicles
    Chong Jun Xu, William Edward Klunk, Julian N. Kanfer, Qing Ping Xiong, Germaine Miller, Jay W. Pettegrew · 1996 · Journal of Biological Chemistry
35. Altered redox state of platelet coenzyme Q 10 in Parkinson's disease
    Götz, M. E., Gerstner, A., Harth, R., Dirr, A., Janetzky, B., Kuhn, W., Riederer, P., Gerlach, M. · 2000 · Journal of Neural Transmission
36. Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington?s disease individuals
    Alexander V. Panov, Serena A. Lund, J. Timothy Greenamyre · 2005 · Molecular and Cellular Biochemistry
37. High-performance capillary electrophoresis-pure creatine monohydrate reduces blood lipids in men and women
    Earnest, Conrad P., Almada, Anthony L., Mitchell, Tedd L. · 1996 · Clinical Science
38. Development of 17α‐Estradiol as a Neuroprotective Therapeutic Agent: Rationale and Results from a Phase I Clinical Study
    DYKENS, JAMES A., MOOS, WALTER H., HOWELL, NEIL · 2005 · Annals of the New York Academy of Sciences
39. Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice
    Cristina Cosi, Françis C. Colpaert, Wouter Koek, Anne-D. Degryse, Marc R. Marien · 1996 · Brain Research
40. [18F]Fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies
    Jean-Christophe G. Antoine, Luc Cinotti, Caroline Tilikete, Françoise Bouhour, J. P. Camdessanch�, Christian Confavreux, Alain Vighetto, V. Renault‐Mannel, D Michel, Jérôme Honnorat · 2000 · Annals of Neurology
41. Ischemia-induced alterations in sarcoplasmic reticulum Ca(2+)-ATPase activity in rat soleus and EDL muscles
    Green, H. J., McKee, N. H., Carvalho, A. J., Dossett-Mercer, J. C. · 1996 · American Journal of Physiology-Cell Physiology
42. Safety and Efficacy of Idebenone versus Tacrine in Patients with Alzheimer's Disease: Results of a Randomized, Double-Blind, Parallel-Group Multicenter Study
    Gutzmann, H., Kühl, K.-P., Hadler, D., Rapp, M. A. · 2002 · Pharmacopsychiatry
43. Preincubation with Creatine Enhances Levels of Creatine Phosphate and Prevents Anoxic Damage in Rat Hippocampal Slices
    Adrian J. Carter, R. ENZIO MULLER, Uwe Pschorn, Werner Stransky · 1995 · Journal of Neurochemistry
44. Additive Neuroprotective Effects of Creatine and a Cyclooxygenase 2 Inhibitor Against Dopamine Depletion in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease
    Péter Klivènyi, Gabrielle Gardian, Noel Ylagan Calingasan, Lichuan Yang, M. Flint Beal · 2003 · Journal of Molecular Neuroscience
45. Ischemia/Reperfusion Impairs Mitochondrial Energy Conservation and Triggers O 2 − Release as a Byproduct of Respiration
    Hans Nohl, Vitali K. Koltover, Klaus Stolze, Harald Esterbauer · 1993 · Free Radical Research Communications
46. Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine
    Simone Beretta, Gessica Sala, Laura Mattavelli, Chiara Ceresa, Arianna Casciati, Alberto Ferri, Maria Teresa Carrı̀, Carlo Ferrarese · 2003 · Neurobiology of Disease
47. Relations Between Tocopherol Depletion and Coenzyme Q During Lipid Peroxidation in rat Liver Mitochondria
    Heiko Noack, Ullrich Kube, Wolfgang Augustin · 1994 · Free Radical Research
48. Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue
    Robert H. Andres, Alexander W. Huber, Uwe Schlattner, Alberto Pérez-Bouza, Sandra H. Krebs, Rolf Walter Seiler, Theo Wallimann, H.R. Widmer · 2005 · Neuroscience
49. Electron transfer complex I defect in idiopathic dystonia
    R. Benecke, Petra Strümper, Hanns Weiss · 1992 · Annals of Neurology
50. Neuroprotective effects of creatine administration against NMDA and malonate toxicity
    César Malcon, Rima F Kaddurah-Daouk, M. Flint Beal · 2000 · Brain Research
51. Ultrastructural study of mitochondria in the spinal cord of transgenic mice with a G93A mutant SOD1 gene
    Shoichi Sasaki, Hitoshi Warita, Tetsuro Murakami, Koji Abe, Makoto Iwata · 2004 · Acta Neuropathologica
52. Idebenone in senile dementia of Alzheimer type: A multicentre study
    Senin, Umberto, Parnetti, Lucilla, Barbagallo-Sangiorgi, Giuseppe, Bartorelli, Luisa, Bocola, Vittorio, Capurso, Antonio, Cuzzupoli, Marco, Denaro, Mario, Marigliano, Vincenzo, Tammaro, Aldo E. et al. · 1992 · Archives of Gerontology and Geriatrics
53. Creatine Diet Supplement for Spinal Cord Injury: Influences on Functional Recovery and Tissue Sparing in Rats
    Rabchevsky, Alexander G., Sullivan, Patrick G., Fugaccia, Isabella, Scheff, Stephen W. · 2003 · Journal of Neurotrauma
54. 3-Nitropropionic Acid Increases the Intracellular Ca2+in Cultured Astrocytes by Reverse Operation of the Na+–Ca2+Exchanger
    Shripad B. Deshpande, Atsuo Fukuda, Hitoo Nishino · 1997 · Experimental Neurology
55. An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients
    Sohmiya, Makoto, Tanaka, Makoto, Suzuki, Yoko, Tanino, Yutaka, Okamoto, Koichi, Yamamoto, Yorihiro · 2005 · Journal of the Neurological Sciences
56. Water-soluble formulation of Coenzyme Q10 inhibits Bax-induced destabilization of mitochondria in mammalian cells
    Jafar Naderi, Mallika Somayajulu‐Nitu, Amit Mukerji, Priya Roy Sharda, Marianna Sikorska, Henryk Borowy‐Borowski, Bruno E. Antonsson, Siyaram Pandey · 2006 · APOPTOSIS
57. ‘Pore’ formation is not required for the hydroperoxide-induced Ca2+ release from rat liver mitochondria
    Jürgen Schlegel, Matthias Schweizer, Christoph Richter · 1992 · Biochemical Journal
58. Untitled work
    1997 · PubMed
59. Effects of 3‐Nitropropionic Acid on Synaptosomal Energy and Transmitter Metabolism: Relevance to Neurodegenerative Brain Diseases
    Maria Erecińska, DAVID S. NELSON · 1994 · Journal of Neurochemistry
60. Re-evaluation of the dysfunction of mitochondrial respiratory chain in skeletal muscle of patients with Parkinson?s disease
    Winkler-Stuck, K., Kirches, E., Mawrin, C., Dietzmann, K., Lins, H., Wallesch, C.-W., Kunz, W. S., Wiedemann, F. R. · 2005 · Journal of Neural Transmission
61. Protective effects of oral creatine supplementation on spinal cord injury in rats
    Hausmann, ON, Fouad, K, Wallimann, T, Schwab, ME · 2002 · Spinal Cord
62. Inhibition of the α-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation
    Huang, Hsueh-Meei, Zhang, Hui, Xu, Hui, Gibson, Gary E · 2003 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
63. Preformed β-amyloid fibrils are destabilized by coenzyme Q10 in vitro
    Kenjiro Ono, Kazuhiro Hasegawa, Hironobu Naiki, Masahito Yamada · 2005 · Biochemical and Biophysical Research Communications
64. Creatine Supplementation Improves Dopaminergic Cell Survival and Protects against MPP+ Toxicity in an Organotypic Tissue Culture System
    Robert H. Andres, Angélique Ducray, Alberto Pérez-Bouza, Uwe Schlattner, Alexander W. Huber, Sandra H. Krebs, Rolf Walter Seiler, Theo Wallimann, Hans Ruedi Widmer · 2005 · Cell Transplantation
65. Effects of creatine treatment on survival and differentiation of GABA‐ergic neurons in cultured striatal tissue
    Robert H. Andres, Angélique Ducray, Alexander W. Huber, Alberto Pérez-Bouza, Sandra H. Krebs, Uwe Schlattner, Rolf Walter Seiler, Theo Wallimann, H. R. Widmer · 2005 · Journal of Neurochemistry
66. l-Carnitine protects neurons from 1-methyl-4-phenylpyridinium-induced neuronal apoptosis in rat forebrain culture
    Wang, C., Sadovova, N., Ali, H.K., Duhart, H.M., Fu, X., Zou, X., Patterson, T.A., Binienda, Z.K., Virmani, A., Paule, M.G. et al. · 2007 · Neuroscience
67. Therapeutic Effects of Coenzyme Q10 in Neurodegenerative Diseases
    M. Flint Beal · 2004 · Methods in enzymology on CD-ROM/Methods in enzymology
68. Evidence for the Involvement of a Membrane-Associated Cyclosporin-A-Binding Protein in the Ca2+-Activated Inner Membrane Pore of Heart Mitochondria
    Larisa V. Andreeva, Ahmed Tanveer, Martin Crompton · 1995 · European Journal of Biochemistry
69. Anoxic ATP depletion in neonatal mice brainstem is prevented by creatine supplementation
    Bernd Wilken, Jan‐Marino Ramirez, Irmelin Probst, Diethelm Wolfgang Richter, Folker A. Hanefeld · 2000 · Archives of Disease in Childhood Fetal & Neonatal
70. Huntington’s Disease and Mitochondrial DNA Deletions: Event or Regular Mechanism for Mutant Huntingtin Protein and CAG Repeats Expansion?!
    Mohammad Mehdi Banoei, Massoud Houshmand, Mehdi Shafa Shariat Panahi, Parvin Shariati, Maryam Rostami, Masoumeh Dehghan Manshadi, Tayebeh Majidizadeh · 2007 · Cellular and Molecular Neurobiology
71. Mutations in mitochondrial‐encoded cytochrome c oxidase subunits I, II, and III genes detected in Alzheimer's disease using single‐strand conformation polymorphism
    Natasha S. Hamblet, Brian D. Ragland, Mervat Ahmed Ali, Barbara Conyers, Frank J. Castora · 2005 · Electrophoresis
72. Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates
    Bodis-Wollner, I., Chung, E., Ghilardi, M. F., Glover, A., Onofrj, M., Pasik, P., Samson, Y. · 1991 · Journal of Neural Transmission - Parkinson's Disease and Dementia Section
73. Ultrastructural study of aggregates in the spinal cord of transgenic mice with a G93A mutant SOD1 gene
    Shoichi Sasaki, Hitoshi Warita, Tetsuro Murakami, Noriyuki Shibata, Takashi Komori, Koji Abe, Makio Kobayashi, Makoto Iwata · 2004 · Acta Neuropathologica
74. MDA, oxypurines, and nucleosides relate to reperfusion in short-term incomplete cerebral ischemia in the rat
    Giuseppe Lazzarino, Roberto Vagnozzi, Barbara Tavazzi, Francesco Saverio Pastore, Donato Di Pierro, P. Siragusa, Antonio Belli, Renato Giuffre, Bruno Giardina · 1992 · Free Radical Biology and Medicine
75. In situ hybridization analysis of CHOT1, a creatine transporter, in the rat central nervous system
    H. Kevin Happe, L. Charles Murrin · 1995 · The Journal of Comparative Neurology
76. Cyclosporin A attenuates degeneration of dopaminergic neurons induced by 6-hydroxydopamine in the mouse brain
    Kouji Matsuura, Hideaki Kabuto, Hiroshi Makino, Norio Ogawa · 1996 · Brain Research
77. Accumulation of analgo of phosphocreatine in muscle of chicks fed 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine).
    G. R. Griffiths, James B. Walker · 1976 · Journal of Biological Chemistry
78. Quantitative study of mitochondrial complex I in platelets of parkinsonian patients
    Blandini, Fabio, Nappi, Giuseppe, Timothy Greenamyre, J. · 1998 · Movement Disorders
79. Complexes between hexokinase, mitochondrial porin and adenylate translocator in brain: regulation of hexokinase, oxidative phosphorylation and permeability transition pore
    Gisela Beutner, Alexander Rück, Birgit Riede, Dieter G. Brdiczka · 1997 · Biochemical Society Transactions
80. Utilization of Cyclocreatine Phosphate, an Analogue of Creatine Phosphate, by Mouse Brain During Ischemia and Its Sparing Action on Brain Energy Reserves
    Dennis T. Woznicki, James B. Walker · 1980 · Journal of Neurochemistry
81. Coenzyme Q10 protects SHSY5Y neuronal cells from beta amyloid toxicity and oxygen‐glucose deprivation by inhibiting the opening of the mitochondrial permeability transition pore
    Li, Geng, Zou, Liang‐Yu, Cao, Chun‐Mei, Yang, Edward S. · 2005 · BioFactors
82. Inhibition of Rat Liver Mitochondrial Permeability Transition by Respiratory Substrates
    Maria Pia Rigobello, Federica Turcato, Alberto Bindoli · 1995 · Archives of Biochemistry and Biophysics
83. Creatine enhances survival of glutamate‐treated neuronal/glial cells, modulates Ras/NF‐κB signaling, and increases the generation of reactive oxygen species
    Elena Juravleva, Tamar Barbakadze, David Mikeladze, Téa Kekelidze · 2004 · Journal of Neuroscience Research
84. Creatine and Cyclocreatine Effects on Ischemic Myocardium: 31 P Nuclear Magnetic Resonance Evaluation of Intact Heart
    Mary D. Osbakken, Kinji Ito, Danning Zhang, Ihor Ponomarenko, Tamás Ivanics, Edwin G. E. Jahngen, Mildred Cohn · 2008 · Cardiology
85. Mitochondria-Directed Therapeutics
    Jeffrey S. Armstrong · 2007 · Antioxidants and Redox Signaling
86. Is Antioxidant Potential of the Mitochondrial Targeted Ubiquinone Derivative MitoQ Conserved in Cells Lacking mtDNA?
    Chao Lü, Dawei Zhang, Matthew Whiteman, Jeffrey S. Armstrong · 2007 · Antioxidants and Redox Signaling
87. Energy Metabolism and Quantal Acetylcholine Release: Effects of Botulinum Toxin, l‐Fluoro‐2,4‐Dinitrobenzene, and Diamide in the Torpedo Electric Organ
    Yves Dunant, Françoise Loctin, Jordi Marsal, Dominique Müller, Á. Párducz, Xavier Rabasseda · 1988 · Journal of Neurochemistry
88. Mitochondrial DNA rearrangements in young onset parkinsonism: two case reports
    Gabriele Siciliano · 2001 · Journal of Neurology Neurosurgery & Psychiatry
89. Energy metabolism of skeletal muscle containing cyclocreatine phosphate. Delay in onset of rigor mortis and decreased glycogenolysis in response to ischemia or epinephrine.
    Thomas M Annesley, James B. Walker · 1980 · Journal of Biological Chemistry
90. Creatine treatment in MELAS.
    L Hagenfeldt, U von Döbeln, G Solders, L Kaijser · 1994 · PubMed
91. Cytoplasmic Transfer of Platelet mtDNA from Elderly Patients with Parkinson's Disease to mtDNA-less HeLa Cells Restores Complete Mitochondrial Respiratory Function
    Yuko Aomi, Chu-Shih Chen, Kazuto Nakada, Sayaka Ito, Kotoyo Isobe, Haruka Murakami, Shinya Kuno, Masato Tawata, Rumiko Matsuoka, Hidehiro Mizusawa et al. · 2001 · Biochemical and Biophysical Research Communications
92. Metabolic alterations produced by 3-nitropropionic acid in rat striata and cultured astrocytes: quantitative in vitro 1H nuclear magnetic resonance spectroscopy and biochemical characterization
    M.J Tsai, C.C Goh, Yongling Wan, C Chang · 1997 · Neuroscience
93. Differential gene expression in a cell culture model of SOD1-related familial motor neurone disease
    Janine Kirby · 2002 · Human Molecular Genetics
94. Creatine treatment promotes differentiation of GABA‐ergic neuronal precursors in cultured fetal rat spinal cord
    Angélique Ducray, Janine-Ai Schlaeppi, Rachel Qualls, Robert H. Andres, Rolf Walter Seiler, Uwe Schlattner, Theo Wallimann, Hans Rudolf Widmer · 2007 · Journal of Neuroscience Research
95. Creatine improves health and survival in mice
    Tobias B. Haack, Andreas Bender, Johannes Beckers, SM Hölter, Tanja Ruthsatz, Daniela M. Vogt Weisenhorn, Lore Becker, Just Genius, Dan Rujescu, Martin Irmler et al. · 2007 · Aktuelle Neurologie
96. Testing a Novel Strategy Against Parkinson's Disease
    Jennifer Couzin · 2007 · Science
97. Age-Related Changes in Swine Brain Creatine Kinase-Catalyzed 31 P Exchange Measured In vivo Using 31 P NMR Magnetization Transfer
    Ronald J. T. Corbett, Abbot R. Laptook · 1994 · Journal of Cerebral Blood Flow & Metabolism
98. Two point mutations in mitochondrial DNA of cytochrome c oxidase coexist with normal mtDNA in a patient with Alzheimer’s disease
    Xiaozhong Qiu, Yuan Chen, Mei Zhou · 2001 · Brain Research
99. Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10
    Brouillet, Emmanuel, Henshaw, D.Ross, Schulz, Jörg B., Beal, M.Flint · 1994 · Neuroscience Letters
100. Feeding a creatine analogue delays ATP depletion and onset of rigor in ischemic heart
     J Roberts, James B. Walker · 1982 · American Journal of Physiology-Heart and Circulatory Physiology
101. Phosphocreatine Synthesis by Isolated Rat Skeletal Muscle Mitochondria Is Not Dependent upon External ADP: A 31P NMR Study
     Florence Kernec, Nathalie Le Tallec, Lydie Nadal‐Desbarats, Jean‐Marc Bégué, Élisabeth Le Rumeur · 1996 · Biochemical and Biophysical Research Communications
102. Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson’s disease
     Isobe, Chiaki, Murata, Takahiko, Sato, Chigumi, Terayama, Yasuo · 2007 · Journal of Clinical Neuroscience
103. Enhanced ability of skeletal muscle containing cyclocreatine phosphate to sustain ATP levels during ischemia following beta-adrenergic stimulation.
     D M Turner, James B. Walker · 1987 · Journal of Biological Chemistry
104. Relative abilities of phosphagens with different thermodynamic or kinetic properties to help sustain ATP and total adenylate pools in heart during ischemia
     David M. Turner, James B. Walker · 1985 · Archives of Biochemistry and Biophysics
105. Neurochemical correlates of differential neuroprotection by long-term dietary creatine supplementation
     Emiliano Peña‐Altamira, Christophe Crochemore, Marco Virgili, Antonio Contestabile · 2005 · Brain Research
106. Attenuation by creatine of myocardial metabolic stress in Brattleboro rats caused by chronic inhibition of nitric oxide synthase
     Dumitru Constantin‐Teodosiu, Paul Leonard Greenhaff, Sheila Margaret Gardiner, Michael D. Randall, Julie E. March, Terence Bennett · 1995 · British Journal of Pharmacology
107. ENHANCEMENT OF THE RECOVERY OF RAT HEARTS AFTER PROLONGED COLD STORAGE BY CYCLOCREATINE PHOSPHATE1,2
     Salwa A. Elgebaly, ZONGJIE WEI, EDWARD TYLES, Ashraf F. El-Kerm, Stuart Lair Houser, Gillies Cc, Rima F Kaddurah-Daouk · 1994 · Transplantation
108. NIH Announces Phase III Clinical Trial of Creatine for Parkinson's Disease
     Marlene Z Bloom · 2007 · PsycEXTRA Dataset
109. Effect of phosphomonoesters, phosphodiesters, and phosphocreatine on glutamate uptake by synaptic vesicles
     Chong Jun Xu, Julian N. Kanfer, William Edward Klunk, Qing Ping Xiong, Richard J. McClure, Jay W. Pettegrew · 1997 · Molecular and Chemical Neuropathology
110. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights substrates of disability
     Sperfeld · 1999 · Pure Amsterdam UMC
111. Increased activity of surviving locus ceruleus neurons in Alzheimer's disease
     Moser · 1999 · Pure Amsterdam UMC
112. Untitled work
     2000 · 10.1002/1531-8249(200011)48:5